Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 2
1998 1
1999 2
2000 2
2001 1
2003 3
2005 3
2006 2
2007 3
2008 6
2009 5
2010 2
2011 3
2012 4
2013 13
2014 8
2015 10
2016 11
2017 15
2018 10
2019 11
2020 7
2021 12
2022 9
2023 10
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension.
Hoeper MM, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, McLaughlin VV, Preston IR, Souza R, Waxman AB, Grünig E, Kopeć G, Meyer G, Olsson KM, Rosenkranz S, Xu Y, Miller B, Fowler M, Butler J, Koglin J, de Oliveira Pena J, Humbert M; STELLAR Trial Investigators. Hoeper MM, et al. Among authors: waxman ab. N Engl J Med. 2023 Apr 20;388(16):1478-1490. doi: 10.1056/NEJMoa2213558. Epub 2023 Mar 6. N Engl J Med. 2023. PMID: 36877098 Clinical Trial.
Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension.
Humbert M, McLaughlin V, Gibbs JSR, Gomberg-Maitland M, Hoeper MM, Preston IR, Souza R, Waxman AB, Ghofrani HA, Escribano Subias P, Feldman J, Meyer G, Montani D, Olsson KM, Manimaran S, de Oliveira Pena J, Badesch DB. Humbert M, et al. Among authors: waxman ab. Eur Respir J. 2023 Jan 6;61(1):2201347. doi: 10.1183/13993003.01347-2022. Print 2023 Jan. Eur Respir J. 2023. PMID: 36041750 Free PMC article. Clinical Trial.
Response.
Nathan SD, Waxman AB. Nathan SD, et al. Among authors: waxman ab. Chest. 2023 Jul;164(1):e22. doi: 10.1016/j.chest.2023.04.016. Chest. 2023. PMID: 37423705 No abstract available.
Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial.
Souza R, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, McLaughlin VV, Preston IR, Waxman AB, Grünig E, Kopeć G, Meyer G, Olsson KM, Rosenkranz S, Lin J, Johnson-Levonas AO, de Oliveira Pena J, Humbert M, Hoeper MM. Souza R, et al. Among authors: waxman ab. Eur Respir J. 2023 Sep 21;62(3):2301107. doi: 10.1183/13993003.01107-2023. Print 2023 Sep. Eur Respir J. 2023. PMID: 37696565 Free PMC article.
Inhaled Treprostinil Dosage in Pulmonary Hypertension Associated With Interstitial Lung Disease and Its Effects on Clinical Outcomes.
Nathan SD, Deng C, King CS, DuBrock HM, Elwing J, Rajagopal S, Rischard F, Sahay S, Broderick M, Shen E, Smith P, Tapson VF, Waxman AB. Nathan SD, et al. Among authors: waxman ab. Chest. 2023 Feb;163(2):398-406. doi: 10.1016/j.chest.2022.09.007. Epub 2022 Sep 15. Chest. 2023. PMID: 36115497 Free PMC article. Clinical Trial.
Phosphodiesterase-5 inhibitors.
Cockrill BA, Waxman AB. Cockrill BA, et al. Among authors: waxman ab. Handb Exp Pharmacol. 2013;218:229-55. doi: 10.1007/978-3-642-38664-0_10. Handb Exp Pharmacol. 2013. PMID: 24092343 Review.
The Dyspnea Clinic.
Ryan JJ, Waxman AB. Ryan JJ, et al. Among authors: waxman ab. Circulation. 2018 May 8;137(19):1994-1996. doi: 10.1161/CIRCULATIONAHA.117.029769. Circulation. 2018. PMID: 29735586 No abstract available.
139 results